Day: March 20, 2020

In response to COVID-19 outbreak, Northern Horizon Capital AS, the management company of Baltic Horizon Fund (the Fund) has taken assertive action to manage the risks arising from the pandemic and to protect the health and safety of the public, our tenants, employees and the operating partners. We are closely monitoring the developments surrounding the outbreak and diligently implementing the instructions of WHO and the national health authorities. Baltic Horizon Fund will keep all its stakeholders informed on the most important actions we have initiated and will aim to ensure that we do everything in our power to prevent further spread of the virus, ensure continuity of our business and minimize the risks to our investors.We are witnessing significant shifts in the operating environment across the Baltic region and anticipate the disruptions...

Vastuseks COVID-19 puhangule on Northern Horizon Capital AS, Baltic Horizon Fondi (edaspidi Fond) fondivalitseja võtnud kindlakäelisi meetmeid pandeemiast tulenevate riskide juhtimiseks ja avalikkuse, meie üürnike, töötajate ja partnerite ohutuse tagamiseks. Jälgime tähelepanelikult haiguspuhanguga seotud arenguid ning rakendame hoolikalt WHO ja riiklike tervisametite juhiseid. Baltic Horizon Fond hoiab kõiki oma sidusrühmi kursis kõige olulisemate Fondi tegevustega ning on võtnud eesmärgiks tagada, et teeme kõik endast oleneva tõkestamaks viiruse edasist levikut, tagada meie tegevuse järjepidevus ja minimeerida riskid investoritele.Oleme tunnistajaks olulistele muutustele ärikeskkonnas kogu Baltikumis ja arvame, et häired majanduses püsivad ka lähiajal. Kõik kolm Balti riiki on reageerinud COVID-19 leviku aeglustamiseks erinevate meetmetega...

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2019. The financial results remained unchanged compared to the preliminary disclosure on 14 February 2020.Distributions to unitholders for 2019 Fund resultsIn total, the Fund declared a cash distribution of EUR 11,309 thousand from the operating results of 2019 (EUR 2,449 thousand from Q1 2019, EUR 2,624 thousand from Q2 2019, EUR 3,061 thousand from Q3 2019 and EUR 3,175 thousand from Q4 2019). Dividends for the operating results of 2019 correspond to a gross yield of 8.0% based on the closing price on the Nasdaq Tallinn Stock Exchange at 31 December 2019.Net profit and net rental incomeIn 2019, the Group recorded a net profit of EUR 8.8 million, which was a down 12.0%, compared to net profit of EUR...

In response to COVID-19 outbreak, Northern Horizon Capital AS, the management company of Baltic Horizon Fund (the Fund) has taken assertive action to manage the risks arising from the pandemic and to protect the health and safety of the public, our tenants, employees and the operating partners. We are closely monitoring the developments surrounding the outbreak and diligently implementing the instructions of WHO and the national health authorities. Baltic Horizon Fund will keep all its stakeholders informed on the most important actions we have initiated and will aim to ensure that we do everything in our power to prevent further spread of the virus, ensure continuity of our business and minimize the risks to our investors.We are witnessing significant shifts in the operating environment across the Baltic region and anticipate the disruptions...

2020 OutlookBoulogne-Billancourt (France), February 20th 2020 – The environment in which Vallourec operates went through significant changes in recent weeks: the coronavirus epidemic (Covid-19) in the countries where the Group is present, combined with the sudden decline in the price of oil, will have an impact on the Group’s activities, especially in North America where unconventional oil and gas operators are announcing drastic reductions in their drilling plans.It is impossible at this stage to quantify the impact of these factors on Vallourec’s 2020 performance and targets. Therefore, Vallourec suspends the guidance previously communicated. Vallourec, whose teams are determined and mobilized, implements decidedly all the necessary mitigation measures and is accelerating the execution of its cost savings program to deal with the situation,...

Communiqué de Presse ZENEO® AdrénalineNouvelle formulation innovante à fort potentiel commercialRachat des droits mondiaux de développement et commercialisation Dijon, 20 mars 2020CROSSJECT (ISIN: FR0011716265; Mnémo: ALCJ), « specialty pharma » qui développe un portefeuille de médicaments combinés innovants dédiés aux situations d’urgence, annonce que la nouvelle formulation de ZENEO® Adrénaline renforce son fort potentiel commercial et qu’elle a racheté les droits de développement et de commercialisation de ZENEO® Adrénaline.Patrick Alexandre, Président du Directoire de Crossject déclare : « Nous sommes très satisfaits des évolutions de ZENEO® Adrénaline, un de nos produits d’urgence prioritaires. La formule médicamenteuse, innovante par l’absence de composants allergènes et par de très bons résultats de stabilité, procurent à ZENEO®...

Paris, Friday 20 March 2020, 7.30 pm CETNexity has implemented a round of share buybacks, as part of the share buyback programme authorised at the Shareholders’ Meeting of 22 May 2019. The buyback mandate, which was granted to investment services provider ODDO BHF SCA, is for a maximum amount of €10 million.This mandate follows on from the Board of Directors’ decision to buy back shares in the proportion necessary to offset the dilution potentially caused by the vesting of free shares with the Group’s employees.It follows the share buybacks carried out since 2018, under which Nexity bought back 1,195,123 shares (i.e. 2.0% of the share capital) for a total of around €51 million.  AT NEXITY, WE AIM TO SERVE ALL OUR CLIENTS AS THEIR REAL ESTATE NEEDS EVOLVENexity offers the widest range of advice and expertise, products, services and solutions...

Paris, le 20 mars 2020, 19h30 CETNexity annonce avoir mis en œuvre un programme de rachat de ses propres actions, dans le cadre du programme de rachat autorisé par l’Assemblée Générale des actionnaires du 22 mai 2019. Le mandat de rachat, qui a été confié au prestataire de services d’investissement ODDO BHF SCA, porte sur un montant maximum de 10 millions d’euros.Ce mandat s’inscrit dans le prolongement de la décision du Conseil d’administration de procéder au rachat d’actions propres dans la proportion nécessaire pour compenser la dilution potentiellement induite par l’acquisition d’actions attribuées gratuitement aux salariés.Il fait suite aux rachats réalisés depuis octobre 2018 qui ont conduit Nexity à racheter 1.195.123 actions (soit 2,0% du capital), pour un montant total de 51 millions d’euros environ.ACCOMPAGNER TOUTES LES...

VANCOUVER, British Columbia, March 20, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce today that it has chosen to appoint award winning Novotech as the contract research organization (“CRO”) for a planned physician initiated study of NP-120 (Ifenprodil) for COVID-19 infected patients in South Korea. Novotech is an internationally recognized full service CRO known for its experience across Australia, New Zealand, Asia and South Africa, representing emerging markets with a population base of over 3 billion people.Novotech will be working to assist the investigators of the planned study, including supporting all aspects of the clinical trial. After the trial is approved, the Company...

PHOENIX, AZ, March 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – No Borders, Inc. (OTC: NBDR), today announced that the Company’s subsidiary, MediDent Supplies, has begun expedited Air Freight shipments of medical equipment and supplies into its operations center in Phoenix, Arizona with the first shipment scheduled to land within 24 hours. Due to the national demand for medical equipment such as Ventilators, Respirators, Touchless Thermometers, and Autoclaves as well as municipal and hospital demand for PPE and disposables such as DTC3X-N95 Surgical Masks, SMS Isolation Gowns, Latex & Nitrile Gloves, and Ammonia Disinfectant Wipes, in addition to the recent launch of the Company’s “MediDent Supplies Viral Specimen Collection Kit” to support the #StayHomeSaveLives efforts across the country, MediDent Supplies Executives...